GLIMIHOP-PM 1/2

Glimepiride 1/2 mg + Metformin ER 500 mg

 

Triple Combination Offers

 

Offers better glycemic control when monotherapy or dual therapy fails

Corrects defective insulin secretion and peripheral insulin sensitivity

Enhances peripheral glucose uptake & utilization

Reduces hepatic glucose production & insulin resistance

Decreases insulin resistance in the periphery and in the liver resulting in increased insulin dependant glucose

Offers better control on FBG & PPBG 2.3 % Higher FBG Reduction

(IJBCP Vol 1, Issue 3 2012-160-167)